Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01569295 |
|---|---|
| Brief Title: | Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela ) (Tugela) |
| First Submitted : | March 27, 2012 |
| First Submitted that Met QC Criteria : | March 30, 2012 |
| First Posted : | April 3, 2012 (Estimate) |
| Results First Submitted : | December 18, 2017 |
| Results First Submitted that Met QC Criteria : | January 29, 2018 |
| Results First Posted : | February 27, 2018 |
| Certification/Extension First Submitted : | May 24, 2016 |
| Certification/Extension First Submitted that Met QC Criteria : | May 24, 2016 |
| Certification/Extension First Posted : | June 6, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 2, 2020 |
| Last Update Posted : | March 10, 2020 |